These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 842583)
41. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control? Nillius SJ; Bergquist C; Wide L Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612 [TBL] [Abstract][Full Text] [Related]
42. Pituitary-ovarian function after tubal ligation. Alvarez-Sanchez F; Segal SJ; Brache V; Adejuwon CA; Leon P; Faundes A Fertil Steril; 1981 Nov; 36(5):606-9. PubMed ID: 7308505 [TBL] [Abstract][Full Text] [Related]
43. Hormonal effects of the 300 microgram norethisterone (NET) minipill. 3. Comparison of the short-term (2nd month) and medium-term (6th month) effects in 21 subjects. Landgren BM; Lager S; Diczfalusy E Contraception; 1981 Mar; 23(3):269-99. PubMed ID: 6786830 [TBL] [Abstract][Full Text] [Related]
44. Patterns of circulating gonadotropins (LH and FSH), prolactin and ovarian steroids (estradiol and progesterone) during the menstrual cycle in Korean women. Ryu K; Bokza B; Kim K Yonsei Med J; 1979; 20(2):155-61. PubMed ID: 121822 [No Abstract] [Full Text] [Related]
45. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle. Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438 [TBL] [Abstract][Full Text] [Related]
46. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch. de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989 [TBL] [Abstract][Full Text] [Related]
47. [Ultrasonic and hormonal monitoring of the ovaries during mini-dose oral contraception]. Doyen J; Schaaps JP; Lambotte R Contracept Fertil Sex (Paris); 1987 May; 15(5):529-33. PubMed ID: 12268693 [TBL] [Abstract][Full Text] [Related]
48. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent. Jeppsson S; Gershagen S; Johansson ED; Rannevik G Acta Endocrinol (Copenh); 1982 Mar; 99(3):339-43. PubMed ID: 6461995 [TBL] [Abstract][Full Text] [Related]
49. [Amenorrhea and the pill]. Verdino P; Viard R; Harter M Lyon Mediterr Med Med Sud Est; 1983 Jan; 19(2):7067-74. PubMed ID: 12279701 [TBL] [Abstract][Full Text] [Related]
50. Serum gonadotropin and steroid patterns during the normal menstrual cycle. Mishell DR; Nakamura RM; Crosignani PG; Stone S; Kharma K; Nagata Y; Thorneycroft IH Am J Obstet Gynecol; 1971 Sep; 111(1):60-5. PubMed ID: 5096358 [TBL] [Abstract][Full Text] [Related]
51. Circulating hormones, EEG, and performance in psychological tests of women with and without oral contraceptives. Wuttke W; Arnold P; Becker D; Creutzfeldt O; Langenstein S; Tirsch W Psychoneuroendocrinology; 1975; 1(2):141-51. PubMed ID: 1234653 [TBL] [Abstract][Full Text] [Related]
52. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women. Sherman BM; Chapler FK; Crickard K; Wycoff D J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834 [TBL] [Abstract][Full Text] [Related]
53. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs. Lasley BL; Wang CF; Yen SS J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551 [TBL] [Abstract][Full Text] [Related]
54. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations. Wallace EM; Gow SM; Wu FC J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955 [TBL] [Abstract][Full Text] [Related]
55. [Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding]. Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J; Schmidt-Gollwitzer M Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):874-7. PubMed ID: 6819180 [TBL] [Abstract][Full Text] [Related]
56. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486. Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492 [TBL] [Abstract][Full Text] [Related]
58. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486. Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550 [TBL] [Abstract][Full Text] [Related]
59. Effect of a once weekly oral contraceptive upon gonadotrophin and gonadal steroid levels. Tredway DR; Mishell DR Contraception; 1974 Aug; 10(2):159-69. PubMed ID: 4418460 [TBL] [Abstract][Full Text] [Related]
60. Hormonal changes in normal menstrual cycle of Thai women. Werawatgoompa S; Tankeyoon M; Kongseripong R; Chaniyom K; Virutamasen P; Dusitsin N; Boonsiri B Contraception; 1981 Mar; 23(3):301-13. PubMed ID: 6786831 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]